-+ 0.00%
-+ 0.00%
-+ 0.00%

Simcere Pharmaceutical Group Receives China Approval to Begin Clinical Trials for SIM0610 Bispecific Antibody-Drug Conjugate

路透·12/23/2025 09:15:43

登录查看新闻详情